Seraticin
From Wikipedia, the free encyclopedia
 |
This article is an orphan, as few or no other articles link to it. Please introduce links to this page from related articles; suggestions may be available. (February 2009) |
Seraticin is a novel antibiotic developed by scientists at Swansea University able to kill 12 different strains of MRSA, as well as E. coli and C. difficile. The research was funded by leading charity Action Medical Research [1], with support from the Rosetrees Trust. Seraticin was isolated as a compound of less than 500Da molecular weight from the maggot secretions of the common green bottle fly (Lucilia sericata)[1][2]. [3].
[edit] References
- ^ http://www.swan.ac.uk/news_centre/LatestNews/Headline,25710,en.php
- ^ Bexfield A, Bond AE, Roberts EC et al (April 2008). "The antibacterial activity against MRSA strains and other bacteria of a <500Da fraction from maggot excretions/secretions of Lucilia sericata (Diptera: Calliphoridae)". Microbes Infect. 10 (4): 325–33. doi:10.1016/j.micinf.2007.12.011. PMID 18400544.
- ^ http://www.rosetreestrust.co.uk |url=}}
 |
This systemic antibacterial-related article is a stub. You can help Wikipedia by expanding it. |
